clinical evaluation of a vegf inhibitor in patients with livermetastases from solid tumours

Upload: adersh-nair

Post on 08-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours

    1/8

    @ICZBJ 6 L[[DHO@JOS

    SDSBJ) SI]DK7 ]UI]I[JC [SULSJHT FIU KBDODKLB JVLBZLSDIO IF

    ]SN)WN" L VJHF DOADEDSIU DO ]LSDJOS[ XDSA BDVJU

    @JSL[SL[J[ FUI@ [IBDC SZ@IZU[

    [ZE@DSSJC ET 7 LCJU[A/[/Z/

    ELSKA 7 5==4 - 5=

  • 8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours

    2/8

    ELKNHUIZOC DOFIU@LSDIO

    Klokjr ds io if taj cjlcbdjst if lbb cdsjlsjs loc als oiw ejki`j `irj ki``io/ Dt ds

    taj uokiotribblebj loc uoirhlodzjc rlpdc hriwta if kjbbs do taj eicy" `ist td`j irdhdoltjcfri` l sdohbj kjbb hjojtdk `utltdio/ Saj rlpdcby hriwdoh `lss if tdssuj ds rjfjrrjc ls tu`iur/

    Saj prjvlbjokj if klokjr als ejjo dokrjlsdoh jlka yjlr loc dt ds taj bjlcdoh klusj if cjlta if

    pjipbj do `loy cjvjbipjc kiuotrdjs/ Klokjr klo prihrjss doti loy plrt" loy irhlo if taj

    eicy/ Jvjo taiuha ki`pbjtj kurj if klokjr ds oit pissdebj" tajrj lrj `loy trjlt`jots

    lvldblebj ticly wadka lrj ajbpfub do lbbjvdltdoh taj dotjosdty if taj cdsjlsj ti taj `lxd`u`

    loc ti prjvjot taj prihrjssdio if taj cdsjlsj/ Aiwjvjr tajrj lrj si`j `dsejbdjvjs l`ioh

    `ist pjipbj talt klokjr ds lo dokurlebj cdsjlsj loc taj pltdjot als ti ejlr taj d``josj pldo

    tariuhaiut ads bdfj/ Sajrj lrj `loy rjsjlrkajs hidoh io wirbcwdcj do taj purpisj if fdocdoh

    iut l ejttjr trjlt`jot loc si`jtd`js fir taj ki`pbjtj jrlcdkltdio if taj cdsjlsj/

    ]jrtldodoh ti taj `jkalods` loc prihrjssdio if taj klokjr" taj prikjss if

    lohdihjojsds ds vjry d`pirtlot/ Lohdihjojsds ds taj prikjss if cjvjbip`jot if ojw ebiic

    vjssjbs fri` taj prj jxdstdoh iojs !Oltdiolb Klokjr Dostdtutj 5==:$/ Sajsj ojw vjssjbs suppby

    outrdjots loc ixyhjo ti taj tu`iur kjbbs" lbbiwdoh taj rlpdc hriwta/ Doadedtdio if

    lohdihjojsds do loc lriuoc taj rlpdcby hriwdoh kjbbs kiubc jffjktdvjby prjvjot taj

    prihrjssdio if klokjr ti taj itajr sdtjs/ Sicly klokjr rjsjlrkajs kiokjotrltj `irj io

    lohdihjojsds doadedtdio loc tajrj lrj `loy lohdihjojsds doadedtdoh cruhs uocjr kbdodklb

    jvlbultdio do rjkjot yjlrs !OKD 5==:$/

    Hriwta flktirs lrj taj d`pirtlot pri`itjrs if lohdihjojsds loc l`ioh taj` vlskublr

    jocitajbdlb hriwta flktirs !VJHF$ lrj taj njy pblyjrs/ VJHF alvj vdtlb ribj do vlskublr

    pjr`jledbdty loc ojivlskublrdsltdio ![klppltdkkd FL jtl b 5==5" Fjrrlrl O/ Jt lb

  • 8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours

    3/8

    Itajr Dokbusdio Krdtjrdl7

    Jstd`ltjc bdfj jxpjktloky7 ; `iotas Lesibutj Ojutripadb Kiuot !LOK$7

  • 8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours

    4/8

    @IVDOH SI SAJ OJQS ]AL[JSAJ ]UI]I[JC [SULSJHT

    Saj pisdtdvj iutki`j if palsj D stucy ipjojc l wly fir ]SN)WN" taj rjspjktjc cruh

    do taj puebdsajc stucy ti `ivj ti taj ojxt palsj if cjvjbip`jot/ Saj pripisjc strltjhy ds ti

    kiocukt l palsj DDD kbdodklb jvlbultdio ti lssjss taj slfjty loc jffdklky if ]SN)WN ki`plrjc

    wdta l stloclrc kaj`itajrlpy !: fbuiriurlkdb)ixlkdpbltdo)bjunivirdo ^FIBFIQ 3P$/ Sads

    strltjhy ds elsjc io taj ojw trjoc do iokibihy talt usjs vlrdius lotdlohdihjodk suestlokjs"

    jspjkdlbby taj VJHF doadedtirs fir taj trjlt`jot if vlrdius typjs if klokjrs/ Saj palsj D

    jvlbultdio if ]SN)WN do pltdjots wdta bdvjr `jtlstlsjs rjki``jocjc l cisj if

  • 8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours

    5/8

    ULSDIOLBJ IF SAJ ]UI]I[JC [SZCT

    Saj pisdtdvj iutki`j if taj palsj D stucy urhjc ojjc if kiocuktdoh l palsj DDD stucy

    wadka jvlbultjs slfjty loc jffdklky if ]SN)WN do blrhj pipubltdio/ Lohdihjojsds ds ki``iodo klrkdoi`l loc lohdihjodk cruhs wdbb ej `uka jffjktdvj do `ist typjs if klokjrs loc si

    palsj DD klo ej sndppjc/ Lotdlohdihjodk suestlokjs lrj wdcjby ejjo usjc do `loy iokibihy

    trdlbs do rjkjot yjlrs loc dt ds fiuoc ti ej jffjktdvj do `loy klsjs/ Saj pripisjc strltjhy ds

    elsjc io tads dofir`ltdio loc cltl/ ]alsj DDD kbdodklb stucdjs usulbby ki`plrj taj

    jxpjrd`jotlb cruh ti l stloclrc cruh/ Do taj pripisjc stucy ]SN)WN wdbb ej ki`plrjc wdta

    FIBFIQ 3" l stloclrc kaj`itajrlpdk suestlokj/ Kaj`itajrlpy ds taj stloclrc trjlt`jot

    iptdio fir `loy klokjrs" dokbucdoh kibirjktlb klokjr wdta bdvjr `jtlstlsjs/ Saj prikjss if

    rloci`dzltdio wdbb ajbp ti lvidc `loy sjbjktdio ir lbbikltdio edls loc ajbp ti rloci`by

    lssdho taj pltdjots ti jlka trjlt`jot hriups/

    Saj stucy wdbb ej `ubtdkjotrdk loc wdbb alvj sdtjs do cjvjbipjc ls wjbb ls cjvjbipdoh

    kiuotrdjs/ Sajrj wiubc ej `irj sdtjs do taj cjvjbipjc kiuotrdjs sdokj taj prjvlbjokj if

    klokjr als ejjo dokrjlsdoh do `loy cjvjbipjc kiuotrdjs do rjkjot yjlrs/ Saj cisj if ]SN)WN

    wdbb ej

  • 8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours

    6/8

    ]rd`lry Iutki`j Lssjss`jot7

    ]rihrjssdio frjj survdvlb" wdta l `dod`u` if

  • 8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours

    7/8

    @jlsurj`jot if Jffdklky7

    Lbb taj pltdjots wdbb ej d`lhjc wdta Cyol`dk Kiotrlst Joalokjc @lhojtdk Ujsiolokj

    D`lhdoh !CKJ-@UD$ ti cjtjkt taj tu`iur ebiic suppby/ Vlskublrdty loc pjr`jledbdty if

    tu`iur kjbbs wdbb ej lssjssjc ey klbkubltdoh taj edcdrjktdiolb trlosfjr kiostlot !Nd$/

    [lfjty Lssjss`jots7

    Lcvjrsj cruh rjlktdios loc sjrdius lcvjrsj jvjots wiubc ej taj plrl`jtjrs if slfjty

    `jlsurjs/ Lbb suka jvjots wdbb ej rjpirtjc ti spiosirs" tajo ti jtadks ki``dttjj" fibbiwjc ey

    rjhubltiry lutairdtdjs wdtado taj td`j skajcubjs hdvjo ey taj rjhubltiry eicdjs/

    [tltdstdklb Lolbysds7

    Kad squlrj tjst wdbb ej taj `lgir tjst usjc fir taj stltdstdklb lolbysds purpisj wdta l

    prieledbdty !p$ if 2=/=:/ Saj survdvlb rltj !ivjrlbb loc prihrjssdio frjj$ if pltdjots wdbb ej

    `jlsurjc usdoh Nlpblo-@jdjr tjst do eita lr`s/ [l`pbj sdzj wdbb ej klbkubltjc wdta l :=*

    sdhodfdklokj bjvjb loc 4=* piwjr wdta rjspjkt ti taj prjvlbjokj rltj/

    Jtadklb Kiosdcjrltdios7

    ]rdir ti taj ki``jokj`jot if taj stucy" ojkjsslry lpprivlb fir lbb ciku`jots pritikibs"

    [I]s" dofir`jc kiosjot ciku`jots wdbb ej kibbjktjc fri` taj jtadks ki``dttjj/ Sajy wdbb

    lbsi ej dofir`jc wdta lbb sjrdius lcvjrsj jvjots ikkurrdoh curdoh taj stucy io td`j/ Jotdrj

    stucy wdbb ej rjvdjwjc ey DJK ir DUE/ Lbb taj lspjkts if taj stucy wdbb ej jxpbldojc wjbb do

    cjtldb ti jlka pltdjot curdoh taj dofir`jc kiosjot prikjss loc sdhojc cltjc wrdttjo kiosjot

    wdbb ej tlnjo fri` taj`/ Lbb taj cjtldbs if taj suegjkts wdbb ej njpt kiofdcjotdlbby tariuhaiut

    taj stucy/ Saj jotdrj stucy wdbb ej kiocuktjc do lkkirclokj wdta lbb taj kiokjrojc rjhubltdios

    loc hudcjbdojs ti josurj qulbdty rjsjlrka/

  • 8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours

    8/8

    UJFJUJOKJ[